Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| HALOZYME THERAPEUTICS, INC. | 31,500 | reported | 06 Feb 2014 | tx 16+315,245−25,788 |
| Celladon Corp | 29,296 | reported | 12 Mar 2021 | tx 21+420,444 |
| CLINICAL DATA INC | 0 | reported | 13 Apr 2011 | tx 11+105,000−221,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 12 Mar 2021 | GRANT_AWARD | Celladon Corp | 11,875 | 0.00 USD | |
| 12 Mar 2021 | GRANT_AWARD | Celladon Corp | 71,250 | 0.00 USD | deriv |
| 05 Mar 2020 | GRANT_AWARD | Celladon Corp | 1,500 | 7.31 USD | |
| 12 Mar 2020 | GRANT_AWARD | Celladon Corp | 50,000 | 0.00 USD | deriv |
| 05 Sept 2019 | GRANT_AWARD | Celladon Corp | 1,500 | 7.95 USD | |
| 05 Sept 2018 | GRANT_AWARD | Celladon Corp | 1,500 | 7.95 USD | |
| 05 Mar 2018 | GRANT_AWARD | Celladon Corp | 1,500 | 8.03 USD | |
| 05 Sept 2017 | GRANT_AWARD | Celladon Corp | 1,500 | 9.90 USD | |
| 06 Mar 2017 | GRANT_AWARD | Celladon Corp | 1,301 | 8.20 USD | |
| 05 Mar 2019 | GRANT_AWARD | Celladon Corp | 1,500 | 7.95 USD | |
| 21 Mar 2019 | GRANT_AWARD | Celladon Corp | 50,000 | 0.00 USD | deriv |
| 14 Mar 2018 | GRANT_AWARD | Celladon Corp | 60,000 | 0.00 USD | deriv |
| 09 Mar 2017 | GRANT_AWARD | Celladon Corp | 40,000 | 0.00 USD | deriv |
| 18 Aug 2016 | PURCHASE | Celladon Corp | 3,125 | 15.70 USD | |
| 13 Jun 2016 | PURCHASE | Celladon Corp | 100 | 22.17 USD | |
| 13 Jun 2016 | PURCHASE | Celladon Corp | 730 | 22.16 USD | |
| 13 Jun 2016 | PURCHASE | Celladon Corp | 420 | 22.20 USD | |
| 23 May 2016 | PURCHASE | Celladon Corp | 745 | 19.99 USD | |
| 19 May 2016 | PURCHASE | Celladon Corp | 500 | 19.52 USD | first after silence |
| 23 Mar 2016 | GRANT_AWARD | Celladon Corp | 60,699 | 0.00 USD | deriv |
| 06 Feb 2014 | GRANT_AWARD | HALOZYME THERAPEUTICS, INC. | 50,000 | 13.10 USD | deriv |
| 06 Feb 2014 | GRANT_AWARD | HALOZYME THERAPEUTICS, INC. | 31,500 | 0.00 USD | deriv |
| 04 Feb 2014 | EXERCISE | HALOZYME THERAPEUTICS, INC. | 4,864 | 0.00 USD | |
| 02 Feb 2014 | EXERCISE | HALOZYME THERAPEUTICS, INC. | 10,387 | 0.00 USD | |
| 02 Feb 2014 | EXERCISE | HALOZYME THERAPEUTICS, INC. | 1,242 | 0.00 USD |
1 purchase reported after at least 12 months of silence — most recent on 19 May 2016.